Plenary Sessions-17/04/2020

Friday, April 17th, 2020

10:30 – 10:45

Congress Opening: Anna Falanga, Benjamin Brenner, Alok A Khorana

 10:45 – 13:00

Plenary Session 1: New Insights In Prevalence of Cancer-Associated Thrombosis

Chairs: H Liebman (USA), Matti Aapro (Switzerland)

PL01 -Screening for Occult Cancer: Where Are We in 2020?
L Jara-Palomares (Spain)

PL02 - An overview of thrombotic complications of old and new anti-cancer drugs
M Levi (The Netherlands)

PL03 - Impact of arterial thrombosis in cancer patients
SC Cannegieter (The Netherlands)

PL04 - Cancer associated thrombosis in pediatric setting
G Kenet (Israel)

Selected Abstract

13:00 - 14:00

Lunch Sessions

14:00 - 14:20

Coffee and pastries

14:20 – 16:35

Plenary Session 2: Biomarkers in CAT and cancer progression

Chairs: N Mackman (USA), AK Olsson (Sweden)

PL05 - Impact of preclinical variables on thrombotic biomarkers levels in cancer
A Lee (Canada)

PL06 - Biomarkers in cancer VTE: Data from the AVERT study
N Key (USA)

PL07 - Thrombotic biomarkers in occult cancer and cancer risk prediction
M Marchetti (Italy)

PL08 - Genes and proteins associated with CAT risk
H Versteeg (The Netherlands)

PL09 - Role of NETs in cancer associated-thrombosis
S Zeerleder (Switzerland)

Selected Abstract

16:35 - 17:05

Coffee break

17:05 – 18:05

Roundtable: Risk assessment models for VTE in cancer

Chairs: P Angchaisuksiri (Thailand), Cihan Ay (Austria)

Introduction: Overview of risk assessment models for VTE in ambulatory patients with cancer
G Gerotziafas (France)

Discussants: A Falanga (Italy), N Van Es (The Netherlands), AA Khorana (USA), MB Donati (Italy), G Gerotziafas (France)

 18.05 – 19.00

Special Lecture

Introduction to Lecture
C Rizzi (Italy)

Are the new technologies useful to medicine or the opposite? 
A Remuzzi (Italy)

 19:00 - 20:00

Welcome Reception